- 专利标题： PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CHRONIC RENAL DISEASE INCLUDING GLUCAGON DERIVATIVE
-
申请号： US18285753申请日： 2022-04-11
-
公开(公告)号： US20240197834A1公开(公告)日： 2024-06-20
- 发明人: Seon Myeong LEE , Jong Suk LEE , Jung Kuk KIM , Eun Jin PARK
- 申请人： HANMI PHARM. CO., LTD.
- 申请人地址： KR Hwaseong-si, Gyeonggi-do
- 专利权人： HANMI PHARM. CO., LTD.
- 当前专利权人： HANMI PHARM. CO., LTD.
- 当前专利权人地址： KR Hwaseong-si, Gyeonggi-do
- 优先权： KR 20210046648 2021.04.09
- 国际申请： PCT/KR2022/005188 2022.04.11
- 进入国家日期： 2023-10-05
- 主分类号： A61K38/26
- IPC分类号： A61K38/26 ; A61K47/68 ; A61P13/12
摘要：
Provided are a glucagon derivative and use thereof. The pharmaceutical composition contains a glucagon derivative and a pharmaceutically acceptable excipient, wherein the glucagon derivative is a peptide including an amino acid sequence of the following General Formula 1: X1-X2-QGTF-X7-SD-X10-S-X12-X13-X14-X15-X16-X17-X18-X19-X20-X21-F-X23-X24-W-L-X27-X28-X29-X30 (General Formula 1, SEQ ID NO: 46). A method for treating chronic renal disease is also disclosed.
信息查询
IPC分类:
